ATDBio
Private Company
Total funding raised: $3.5M
Overview
ATDBio is a private, revenue-generating service provider and partner in the oligonucleotide synthesis space, headquartered in Southampton, UK. The company's core business is providing custom, high-purity oligonucleotides and associated technical support to research, diagnostic, and therapeutic development clients. Its differentiation lies in deep chemical insight, flexibility in handling complex modifications, and a collaborative partnership model, as evidenced by strategic collaborations with companies like YouSeq and NATA. ATDBio operates primarily as a B2B service provider rather than developing its own therapeutic pipeline.
Technology Platform
Deep expertise in oligonucleotide chemistry enabling optimal design, synthesis (including complex modifications), purification, and analysis for high-purity yield.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ATDBio competes with large, high-volume oligo suppliers like Integrated DNA Technologies (IDT) and Merck (Sigma-Aldrich), as well as other specialty CROs. Its differentiation is a deep focus on chemical insight, flexibility for complex/modified oligos, and a collaborative service model, rather than competing on price for standard, high-volume orders.